A trial conducted among over 5,300 adolescent girls and young women in South Africa and Uganda, showed zero HIV infections with the injectable lenacapavir, compared to daily oral drugs Descovy and Truvada.
A trial conducted among over 5,300 adolescent girls and young women in South Africa and Uganda, showed zero HIV infections with the injectable lenacapavir, compared to daily oral drugs Descovy and Truvada.